All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
ABBV real return snapshot: after CPI-U inflation, ABBV returned +16.42% over the past year and +11.32% YTD, with dividends reinvested. Since Dec. 10, 2012, ABBV is up +766.97% in real purchasing-power return, or +17.01%/yr, and is currently −3.54% below its real total-return high on Aug. 19, 2026.
Data ending Fri Sep. 11, 2026
| Mon 2012-12-10💬 to Fri 2026-09-11 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| ABBV × |
+766.97%
+17.01%/yr |
+14.48%/yr
R2=0.954 |
||||
| AbbVie Inc NYSE Common Stock | ||||||
| Mon 2012-12-10💬 to Fri 2026-09-11 |
Start
Value |
End
Value |
|---|---|---|
| ABBV × |
$10,000.00
2012-12-10 |
$86,696.69
2026-09-11 |
| YTD | YoY | |
|---|---|---|
| ABBV × | +11.32% | +16.42% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| ABBV × |
−3.54%
on 2026-09-11 from 2026-08-19 peak |
−47.00%
on 2019-08-15 from 2018-01-26 peak |
| Period ending Fri 2026-09-11 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| ABBV × | +16.42% |
+32.56% +15.13%/yr |
+75.38% +20.59%/yr |
+136.47% +18.78%/yr |
+339.75% +15.96%/yr |
| Year | ABBV |
|---|---|
| 2026 (YTD) | +11.32% |
| 2025 | +29.61% |
| 2024 | +15.54% |
| 2023 | −3.47% |
| 2022 | +16.48% |
| 2021 | +23.72% |
| 2020 | +26.00% |
| 2019 | −0.80% |
| 2018 | −2.81% |
| 2017 | +56.76% |
| 2016 | +7.56% |
| 2015 | −7.18% |
| 2014 | +26.96% |
| 2013 | +58.39% |
| 2012 | −2.22% |
